This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego

Scott Gangloff
Vice President, Global Biopharmaceutical Development at Incyte


Scott Gangloff is chemical engineer with almost 30 years of experience in Biopharmaceutical Development and Manufacturing. Scott spent most of his early years at Bristol Myers Squibb, with various responsibilities in Bioprocess Development and Manufacturing, contributing to many currently licensed Biologics programs. In 2011, Scott joined colleagues to create the start-up Oncobiologics, where he was responsible for Process and Product Development of the biosimilars portfolio. In 2017, Scott joined Incyte Corporation where he is currently serving as Vice President, Global Biopharmaceutical Development, responsible for CMC development and related supply chain activities for the large molecule pipeline. During his tenure at Incyte, Scott has been responsible for the submission of numerous INDs and BLAs.

Agenda Sessions

  • KEYNOTE: IND To BLA Technology Transfer Considerations

  • KEYNOTE: IND To BLA Technology Transfer Considerations